Stress
Trauma, PTSD, and Cardiovascular Health
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.
These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.
In Brief: Trauma is an experience; cardiovascular disease is biology — and the link between them is that, for many people, trauma changes the long-running state of the body: lighter sleep, easier-triggered threat vigilance, harder recovery, and more fragile health behaviors. Two categories carry the strongest cardiovascular evidence: PTSD, which has the best prospective outcome data (roughly 55% higher coronary heart disease risk, attenuating but persisting after adjustment for depression), and adverse childhood experiences, which show a graded, dose-response relationship with later ischemic heart disease but rely more on retrospective recall. The associations are consistent but probabilistic, not deterministic — most people with adversity do not develop heart disease. In real life, trauma’s largest cardiovascular lever is rarely a lab value; it is execution — disrupted sleep, medication avoidance, missed follow-up — the behaviors that keep blood pressure, glucose, lipids, and smoking controlled. The practical question is not whether trauma caused heart disease but whether it is quietly interfering with the ability to carry out the prevention plan.
What Trauma Means in Cardiovascular Terms
Trauma is an experience. Cardiovascular disease is biology. The reason this topic matters is that, for many people, trauma does not stay contained in memory or emotion. It changes the long-running operating state of the body: sleep becomes lighter, threat vigilance becomes easier to trigger, recovery becomes harder, and health behaviors become more fragile.
Over years, that combination can affect cardiovascular risk through three broad channels:
- Stress biology that stays “on” too often (autonomic imbalance, neuroendocrine signaling) — the pathways established in Articles 1–3
- Inflammatory and metabolic shifts that accumulate quietly
- Behavior under threat physiology: disrupted sleep, reduced exercise, substance coping, missed follow-up, and medication avoidance — often the largest real-world lever
The American Heart Association’s 2018 scientific statement reviewed this evidence and recognized adverse childhood experiences as a risk factor for cardiometabolic disease across the lifespan. (1)
This article focuses on two evidence-backed categories where the data are strongest and most clinically relevant:
- Adverse Childhood Experiences (ACEs): childhood adversity and long-term adult cardiovascular risk (2,3)
- Post-Traumatic Stress Disorder (PTSD): a defined clinical syndrome with prospective cardiovascular outcome data (4–6)
PTSD has the strongest prospective cardiovascular outcome data in this literature; ACE data are larger epidemiologically but rely more heavily on retrospective measurement and downstream risk-factor pathways.
The hardest part of this topic is not “does it matter?” The hardest part is how to use it — because the exposure is experience, not a lab value with a single target.
Common Assumptions, Measured Against the Evidence
| Common Assumption | What the Evidence Shows |
| Trauma directly causes heart disease. | The associations are consistent and biologically plausible, but observational confounding can inflate them. Trauma is best understood as risk amplification, not a proven direct cause. (1–6) |
| A high ACE score means heart disease is coming. | The relationship is probabilistic, not deterministic. Most people with childhood adversity do not develop heart disease; risk rises in a graded way, and very high scores (≥7 categories) are a small subset. (2,3) |
| PTSD is just depression in disguise. | The coronary risk persists after adjustment for depression (HR 1.27), and a twin study controlling for shared genes and early environment still found more than double the risk — suggesting an effect beyond depression alone. (4,5) |
| Treating PTSD prevents heart attacks. | PTSD treatment reliably reduces PTSD symptoms, and PTSD predicts worse cardiovascular outcomes — but no trial has yet shown that treating it lowers heart attack or stroke rates. (4–6) |
| Trauma sits in the same risk tier as smoking. | Smoking has stronger causal evidence and a larger effect size. Trauma’s cardiovascular weight comes mostly through behavior — adherence, sleep, substance coping — not direct biology. (6,11,12) |
| If medications get skipped, the fix is more willpower. | After a cardiac event, avoidance can drive nonadherence (PTSD: 68% vs 26% in uncontrolled hypertension). The limiting factor is execution, not knowledge — the fix is reducing reminder moments, not trying harder. (6,11) |
Two Trauma Categories With the Strongest Cardiovascular Evidence
Category 1: Adverse Childhood Experiences (ACEs)
ACEs are categories of early adversity — abuse, neglect, and household dysfunction — that correlate with later adult health outcomes. The core finding across ACE research is a dose-response relationship: as ACE categories increase, adult risk rises for multiple outcomes, including behaviors and conditions that strongly shape cardiovascular disease.
The ACE Study (1998): the foundation
Felitti et al. examined over 9,500 adults and described graded relationships between the number of ACE categories and adult disease outcomes. (2) The paper is famous for showing that ACE exposure correlates with later adult health behaviors and disease patterns in a way that is not random.
Key findings in the original report included strong dose-response relationships for substance use, depression, suicide attempts, smoking, physical inactivity, and severe obesity. (2) Those outcomes matter cardiovascularly because they map directly onto the risk-factor pathways that determine events decades later.
ACE and ischemic heart disease (2004): a clearer cardiovascular link
Dong et al. examined ACE–ischemic heart disease relationships in 17,337 adults. (3) Individual ACE categories were associated with higher ischemic heart disease risk, and in those with seven or more ACE categories, the adjusted odds ratio for ischemic heart disease was 3.6 (95% CI 2.4–5.3). (3)
A key interpretive point from Dong et al. is that emotional/psychological pathways (depressed affect, anger) appeared to mediate the relationship strongly — highlighting that trauma’s cardiovascular relevance often runs through the nervous system and behavior, not only through “traditional” risk factors. (3)
How ACE history shows up in real life cardiovascular care
ACE history often becomes clinically visible not as a single diagnosis, but as patterns that repeatedly interfere with risk-factor control:
- sleep fragmentation and hypervigilance
- avoidance of follow-up or testing
- substance coping
- difficulty sustaining routines (nutrition, movement, medications)
That matters because cardiovascular prevention is a long game. A good plan that cannot be executed consistently is not protective.
Important limitations to keep in mind
ACE studies are largely retrospective, relying on adults’ recall of childhood experiences (recall bias), and many cohorts have limited generalizability. (1–3) The AHA scientific statement acknowledged these limitations while concluding that evidence supports an association between childhood adversity and cardiometabolic outcomes across the life course. (1) A major gap remains: there is very little direct evidence that ACE-targeted interventions reduce cardiovascular events later in life. (1)
Category 2: PTSD
PTSD is not just “stress.” It is a defined syndrome characterized by intrusive re-experiencing, avoidance, negative mood/cognition changes, and hyperarousal. When it persists, it can become a chronic physiologic state with downstream cardiovascular relevance.
Prospective cardiovascular risk
Edmondson et al.’s 2013 meta-analysis of six prospective studies (N = 402,274) found PTSD was associated with 55% increased risk of incident coronary heart disease (HR 1.55, 95% CI 1.34–1.79). (4) When adjusted for depression, the association remained significant but attenuated: HR 1.27 (95% CI 1.08–1.49). (4)
That depression-adjusted signal matters because it suggests PTSD is not merely “depression in disguise,” though comorbidity is common and confounding remains important.
Stronger causal inference: the twin study
Vaccarino et al. used Vietnam-era veteran twins discordant for PTSD. The twin with PTSD had more than double the risk of incident coronary heart disease even after controlling for shared genetic and early environmental factors. (5) The within-twin design reduces many confounders because twins share genes and early-life environment.
The bidirectional reality
Edmondson and von Känel (2017) emphasized a clinically important loop: PTSD is both a risk factor for cardiovascular disease and can be a consequence of cardiac events. They estimate approximately 1 in 8 acute coronary syndrome survivors develop PTSD related to the event. (6)
This matters because it creates a plausible secondary-prevention trap: the cardiac event causes PTSD; PTSD then increases risk of recurrence via avoidance, adherence collapse, sleep disruption, and sympathetic activation. (6)
How Trauma Reaches the Cardiovascular System
This section is not about dramatic mechanisms. It is about the few pathways that recur across the evidence and show up in real patient lives.
Pathway 1: Chronic inflammation
Meta-analyses show higher inflammatory markers in PTSD cohorts (for example CRP and IL-6), though heterogeneity is substantial. (7,8) The direction of causality is not fully settled; prospective work suggests inflammation may also predict PTSD risk rather than only result from it. (9)
Why this matters clinically: inflammation is one plausible bridge between chronic threat physiology and atherosclerosis biology, but in practice it is rarely a direct “lab to fix.” It is a reason to take the behavioral foundations seriously — sleep, smoking, metabolic control — because those are the levers that reliably move cardiometabolic risk.
Pathway 2: Autonomic imbalance
PTSD is associated with lower heart rate variability and higher resting heart rate, consistent with chronic sympathetic dominance and reduced parasympathetic tone. (10) Reduced HRV is associated with cardiovascular risk in broader populations, and it is a plausible mechanistic link between persistent hyperarousal and long-term vascular risk. (10)
Clinically, autonomic imbalance is also part of why trauma symptoms can feel physically “cardiac” — palpitations, chest tightness, breathlessness — especially after a cardiac event. (6)
Pathway 3: Behavioral disruption
This is often the highest-yield pathway in real life.
Among primary care patients with uncontrolled hypertension, medication nonadherence was more than twice as common in those with PTSD (68%) compared to those without PTSD (26%), persisting after adjustment for depression. (11)
A key mechanism proposed in the cardiovascular-PTSD literature is avoidance: cardiovascular medications can act as illness reminders, and avoidance symptoms can drive people away from the very behaviors required for prevention. (6,11) When this is happening, escalating medications may not solve the problem — because the limiting factor is execution, not knowledge.
In cardiovascular care, trauma rarely acts like a laboratory abnormality; it acts like an execution problem.
How to Interpret the Evidence (Without Getting Lost in Study Design)
This literature is strong enough to take seriously and limited enough to interpret carefully.
Here is the clean, reader-useful interpretation:
- These associations are consistent. PTSD and high ACE burden repeatedly correlate with higher cardiovascular risk across large populations. (1–6)
- The effect size is not destiny. Most people with adversity do not inevitably develop heart disease. The relationship is probabilistic, not deterministic. (1–4)
- The numbers are not all directly comparable. ACE studies often use odds ratios; PTSD studies use hazard ratios; populations differ; adjustment differs. Calibration is useful, but not precision prediction. (3,4)
- The most actionable meaning is “risk amplification.” Trauma often makes it harder to sustain the behaviors and follow-through that keep blood pressure, glucose, lipids, and smoking controlled — the major drivers of events. (6,11)
This is exactly why trauma belongs in cardiovascular conversations: not as a moral story, and not as a thesis about causality, but as a practical risk-management reality.
Cardiac Event–Induced PTSD: When the Heart Attack Becomes the Trauma
A meaningful minority of acute coronary syndrome survivors develop PTSD related to the event itself — estimated around 12%. (6) That is not a psychiatric footnote. It can become a secondary prevention problem.
Studies reviewed by Edmondson and von Känel describe that post–cardiac event PTSD is associated with roughly twofold higher risk of recurrence or cardiovascular mortality after adjustment for standard risk factors including depression. (6)
The proposed mechanism is again practical and recognizable: medication avoidance and care avoidance. Some patients skip cardiovascular medications because the medications serve as reminders of the event they are trying not to think about. (6) Post-event PTSD can also produce symptoms that mimic cardiac symptoms, driving cycles of avoidance and repeated emergency evaluation — both of which destabilize prevention. (6)
If someone survives a cardiac event and then becomes avoidant of appointments, medications, or monitoring — or develops recurrent episodes of panic-like symptoms — PTSD is a reasonable consideration, not a character judgment. Identifying and treating it is cardiovascular risk management. (6)
Calibration: Where Trauma-Related Risk Fits Relative to Major Risk Factors
These estimates come from different study designs and risk metrics (HR/OR/RR). Treat them as calibration, not direct head-to-head comparisons.
| Risk Factor | Approximate Relative Risk | Evidence Quality |
| Current smoking | 2.0–3.0× | Strong (causal) (12) |
| Diabetes mellitus | ~2.0× | Strong (causal) (13) |
| Hypertension (sustained) | 1.5–2.0× | Strong (causal) (14) |
| High LDL cholesterol (untreated) | ~1.5× per 1 mmol/L | Strong (causal) (15) |
| PTSD (unadjusted) | ~1.55× | Moderate (prospective) (4) |
| PTSD (adjusted for depression) | ~1.27× | Moderate (prospective) (4) |
| ≥7 ACE categories (vs. 0) | ~3.6× ischemic heart disease | Moderate (retrospective) (3) |
| 1–3 ACE categories (vs. 0) | ~1.3–1.7× ischemic heart disease | Moderate (retrospective) (3) |
Two practical clarifications:
- Very high ACE scores (≥7 categories) represent a smaller subset of people; most report 0–2 categories where associated risk increases are more modest. (2,3)
- Confounding matters. Trauma is associated with depression, substance use, sleep disruption, poverty, and health behaviors that independently influence cardiovascular outcomes. (1–6) The twin design and depression-adjusted analyses suggest an independent effect remains, but exact magnitude is uncertain. (4,5)
High ACE burden is also strongly correlated with downstream risk factors (smoking, obesity, depression, sleep disruption, socioeconomic strain), which may partly account for the larger observed effect sizes in retrospective cohorts. (1–3)
Intervention Evidence: What We Can Say Responsibly
What is proven
Evidence-based PTSD treatments — including Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and EMDR — reduce PTSD symptoms in randomized trials. (6)
What is plausible
Improving PTSD symptoms can improve sleep, reduce hyperarousal, improve healthcare engagement, and likely improve medication adherence — pathways that plausibly reduce cardiovascular risk over time. (6,11) Physical activity is a cardiovascular intervention and is also used as an adjunct that can support PTSD recovery in some individuals.
What is not proven
No randomized trial has demonstrated that treating PTSD reduces myocardial infarction or stroke rates. We have evidence that PTSD predicts worse cardiovascular outcomes (4–6) and evidence that PTSD treatment improves PTSD symptoms (6), but we do not yet have cardiovascular endpoint trials that connect those two findings.
What to avoid claiming
- “Trauma causes heart disease.” Observational confounding can inflate effect size. (1–6)
- “Treating PTSD prevents heart attacks.” Not tested in event trials. (6)
- “High ACE score equals heart disease.” It is a risk association, not destiny. (2,3)
- “Trauma is the same as smoking.” Smoking has stronger causal evidence and larger effect size. (12)
Practical Tools: How to Make This Useful in Real Life
This section exists because understanding the mechanism is not enough. The most common way trauma affects cardiovascular outcomes is through execution: sleep disruption, avoidance, adherence friction, and follow-up collapse. (6,11)
These are tools and conversation frames, not prescriptions.
Tool 1: If medications or appointments trigger avoidance
In post–cardiac event PTSD and in PTSD with uncontrolled hypertension, avoidance is a plausible driver of nonadherence. (6,11)
What helps is not willpower. It is reducing the number and intensity of “reminder moments.”
Practical options to discuss with your care team:
- Name the mechanism directly: “I avoid meds/appointments because they remind me of the event.” (6)
- Ask whether simplification is possible in your situation (for example, fewer dosing times).
- Externalize refills: auto-refill and synchronization reduce repeated decision points.
- Use a neutral cue: tie meds to a neutral daily routine (coffee/tea, brushing teeth) rather than “heart reminders.”
Tool 2: If sleep is the main failure point
Sleep fragmentation and hypervigilance are common trauma outputs and can destabilize BP, appetite regulation, glucose, and mood. (1,6)
Practical options:
- Track one simple week: bedtime, wake time, awakenings, caffeine/alcohol timing.
- Tell clinicians specifically whether it is initiation, maintenance, or hyperarousal awakenings.
- If nightmares or panic awakenings are present, that is clinically relevant information to share.
Tool 3: If symptoms blur panic vs cardiac symptoms
After an acute coronary event, trauma symptoms can mimic cardiac symptoms and create cycles of repeated ED visits or dangerous avoidance. (6)
The useful move is not self-diagnosis. It is coordination:
- “I’m having episodes that feel cardiac and also feel like panic.”
- Ask what the plan should be for symptom evaluation in your situation, and what should trigger emergency evaluation.
Tool 4: If coping behaviors are becoming cardiovascular risks
ACEs and trauma exposure correlate with higher rates of smoking and substance coping in the ACE literature, and those behaviors independently drive cardiovascular risk. (2,3,12)
A practical, non-moral question: “What do I do to downshift that might be worsening my cardiovascular risk?”
This reframes coping as a risk-management problem.
Bring to Your Clinician: the few details that actually matter
If trauma history may be affecting cardiovascular risk management, the highest-yield details to bring are:
- sleep pattern (fragmentation, hypervigilance, nightmares) (1,6)
- adherence pattern (missed doses, delayed refills, why it happens) (6,11)
- follow-up avoidance (missed visits, avoided labs, avoided monitoring) (6)
- substance coping patterns (smoking, alcohol, other) (2,3,12)
A simple opener: “I’m managing cardiovascular risk factors, and I think trauma symptoms may be affecting sleep and follow-through. Can we talk about adapting the plan to that reality?” (6)
If this resonates, the goal is not to “try harder.” The goal is designing a plan that fits the nervous system you have — because prevention is only protective if it is executable.
When Trauma History Changes Clinical Management
Trauma history becomes clinically relevant when it plausibly affects risk control — especially medication adherence, sleep quality, substance use, healthcare avoidance, or persistent hyperarousal — because those are levers that determine outcomes. (6,11)
Discussing trauma history with healthcare providers may be appropriate when:
- you have diagnosed PTSD and are managing cardiovascular risk factors
- you have difficulty taking cardiovascular medications consistently and suspect avoidance may play a role (6,11)
- you experienced significant childhood adversity and have multiple risk factors that are difficult to control (1–3)
- you survived a cardiac event and subsequently developed intrusive thoughts, avoidance, or persistent hyperarousal related to the event (6)
Integrated mental health and cardiovascular care matters because PTSD’s strongest cardiovascular leverage often operates through behavior (adherence, sleep, substance coping) more than direct biology. (6,11)
The Decision Rule
Trauma changes what a person can sustain. Cardiovascular prevention depends on what a person can sustain.
That is the bridge between these two worlds.
If trauma history — whether childhood adversity or adult PTSD — is interfering with the behaviors that keep risk factors controlled, naming it is not weakness. It is the first step toward designing a plan that actually works.
The practical question is not “did trauma cause my heart disease?” It is: “Is trauma quietly interfering with my ability to execute the prevention plan?” If yes, the goal is adapting the plan to fit the nervous system you have — because a good plan that cannot be executed is not protective.
The Bottom Line
The evidence supports that ACE burden and PTSD are associated with higher cardiovascular risk, with the strongest prospective evidence for PTSD and a large epidemiologic foundation for ACEs. (1–6) The mechanisms are plausible and include inflammatory signaling, autonomic imbalance, and — most importantly in real life — the behavioral pathways that determine whether blood pressure, glucose, lipids, and smoking stay controlled over years. (6,11–15)
The practical use of this article is not to label trauma as destiny. It is to recognize when trauma is quietly interfering with the core behaviors and follow-through that protect the heart — and to bring that reality into care so the plan can be adapted rather than repeatedly “failed.”
Trauma changes what you can sustain, and prevention is built from what you can sustain. Name it, adapt the plan to the nervous system you actually have, and the plan can finally hold. Own it.
What Comes Next
Article 10 turns to financial stress — a long exposure that pushes cardiovascular risk up biologically while pulling protection away by interrupting medication continuity and care.
Key Terms
Adverse Childhood Experiences (ACEs) — Categories of childhood adversity — including abuse, neglect, and household dysfunction — assessed in the landmark Felitti et al. study. ACE scores show graded relationships with adult health outcomes including ischemic heart disease. (2,3)
Post-Traumatic Stress Disorder (PTSD) — A psychiatric condition following trauma exposure, characterized by intrusive re-experiencing, avoidance, negative mood/cognition changes, and hyperarousal. Associated with increased risk of coronary heart disease in prospective meta-analyses. (4–6)
Heart Rate Variability (HRV) — Variation in time intervals between heartbeats, reflecting autonomic function. PTSD is associated with reduced HRV, consistent with chronic sympathetic dominance. (10)
Medication Nonadherence — Failure to take prescribed medications as directed. In uncontrolled hypertension populations, PTSD has been associated with markedly higher nonadherence. (11)
Cardiac Event–Induced PTSD — PTSD triggered by an acute coronary syndrome or other cardiac event; estimated around 12% of ACS survivors and associated with worse secondary prevention outcomes in observational work. (6)
References
- Suglia SF, Koenen KC, Boynton-Jarrett R, et al. Childhood and adolescent adversity and cardiometabolic outcomes: a scientific statement from the American Heart Association. Circulation. 2018;137(5):e15–e28.
- Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245–258.
- Dong M, Giles WH, Felitti VJ, et al. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation. 2004;110(13):1761–1766.
- Edmondson D, Kronish IM, Shaffer JA, Falzon L, Burg MM. Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J. 2013;166(5):806–814.
- Vaccarino V, Goldberg J, Rooks C, et al. Post-traumatic stress disorder and incidence of coronary heart disease: a twin study. J Am Coll Cardiol. 2013;62(11):970–978.
- Edmondson D, von Känel R. Post-traumatic stress disorder and cardiovascular disease. Lancet Psychiatry. 2017;4(4):320–329.
- Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002–1012.
- Peruzzolo TL, Pinto JV, Roza TH, et al. Inflammatory and oxidative stress markers in post-traumatic stress disorder: a systematic review and meta-analysis. Mol Psychiatry. 2022;27(8):3150–3163.
- Eraly SA, Nievergelt CM, Maihofer AX, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014;71(4):423–431.
- Schneider M, Schwerdtfeger A. Autonomic dysfunction in posttraumatic stress disorder indexed by heart rate variability: a meta-analysis. Psychol Med. 2020;50(12):1937–1948.
- Kronish IM, Lin JJ, Cohen BE, Voils CI, Edmondson D. Posttraumatic stress disorder and medication nonadherence in patients with uncontrolled hypertension. JAMA Intern Med. 2014;174(3):468–470.
- Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet. 2004;364:937–952.
- Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222.
- Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
- Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet. 2005;366:1267–1278.
HeartBuddi • Your heart. Own it.